SCHEMBL7703594

SCHEMBL7703594

O=C(Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 5/20 0.53
KDR P35968 3/20 0.52
POLB P06746 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
MITF O75030 2/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
CDK1 P06493 1/20 0.49
CDK2 P24941 1/20 0.49
PSMB5 P28074 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA7 P43166 1/20 0.46
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
CD40 P25942 2/20 0.45
CD40LG P29965 2/20 0.45
ABCB1 P08183 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6999716 1.00 CHEK1 (0.53) CHEK1KDRPOLBMEN1KMT2A
SCHEMBL7701674 0.90 MEN1 (0.55) CHEK1KDRPOLBMEN1KMT2A
SCHEMBL7167280 0.89 MEN1 (0.48) CHEK1KDRPOLBMEN1KMT2A
SCHEMBL7094928 0.88 KDR (0.64) CHEK1KDRMEN1KMT2ANPC1
SCHEMBL6994408 0.88 KDR (0.64) CHEK1KDRNPC1CDK1CDK2
Water SCHEMBL7089950 0.87 KDR (0.63) CHEK1KDRMEN1KMT2ANPC1
SCHEMBL7000839 0.87 KDR (0.68) CHEK1KDRNPC1CDK1CDK2
SCHEMBL7696243 0.86 CHEK1 (0.57) CHEK1KDRPOLBMEN1KMT2A
SCHEMBL7545158 0.86 CHEK1 (0.40) CHEK1KDRPOLBMEN1KMT2A
SCHEMBL7002081 0.85 CDK1 (0.67) CHEK1KDRPOLBNPC1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed